Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone (Q46585967)
Jump to navigation
Jump to search
scientific article published on 7 November 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone |
scientific article published on 7 November 2012 |
Statements
1 reference
Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone (English)
1 reference
Karim Fizazi
1 reference
Charles J Ryan
1 reference
Mark Rosenthal
1 reference
Siobhan Ng
1 reference
Joshi Alumkal
1 reference
Joel Picus
1 reference
Gwenaƫlle Gravis
1 reference
FrƩdƩric Forget
1 reference
Jean-Pascal Machiels
1 reference
Sandy Srinivas
1 reference
Min Zhu
1 reference
Rui Tang
1 reference
Kelly S Oliner
1 reference
Yizhou Jiang
1 reference
Elwyn Loh
1 reference
Sarita Dubey
1 reference
Winald R Gerritsen
1 reference
7 November 2012
1 reference
19
1 reference
1
1 reference
215-224
1 reference
Identifiers
1 reference